Mesothelioma News and Research

RSS

Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.

Secretome of pleural effusions linked to NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

25 Nov 2019

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

6 Nov 2019

Removing asbestos from schools likely to increase cases of mesothelioma

Removing asbestos from every school in the UK could result in more deaths from mesothelioma than if the asbestos was left in place, claims expert.

9 Jul 2019

Researchers discover novel cancer-promoting molecular mechanism

A novel cancer-promoting molecular mechanism has been discovered by Pierluigi Scalia, M.D., Ph.D., with his co-workers at the Sbarro Institute for Cancer Research and Molecular Medicine, Division of Biology, Temple University, the Department of Medical Biotechnologies at University of Siena, Italy and the Italian non-profit research organization ISOPROG, in collaboration with the Center of Biocomputational Sciences, part of the College of Science and Technology in Philadelphia.

8 Jul 2019

New study points out simple problem with existing model of cancer

The saying "God doesn't play dice" is meant to suggest that nothing happens by chance. On the other hand, cancer seems like the ultimate happenstance: Don't we all have a 43-year-old, vegan, triathlete friend fighting cancer? Does this mean that cancer plays dice?

21 Jun 2019

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the ESTRO 38 conference.

29 Apr 2019

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

New research demonstrating the clinical utility of Bio-Rad's Droplet Digital PCR powered liquid biopsy will be presented this week during the 2019 American Association for Cancer Research Annual Meeting in Atlanta, March 29-April 3.

30 Mar 2019

New combination therapy found to be well tolerated in patients with aggressive brain tumor

A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients.

30 Mar 2019

World's largest AI-powered medical research network launched by OWKIN

OWKIN today announced the world's largest AI-powered medical research network. The OWKIN Loop Network is comprised of 44 prestigious hospitals and research institutions across the US and Europe, including Cleveland Clinic and Mount Sinai.

13 Dec 2018

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.

13 Dec 2018

Asbestos found in most NHS hospitals finds BBC inquiry

An inquiry led by the BBC has found that nine out of ten NHS hospitals have asbestos. The inquiry included 211 trust hospitals of which 198 agreed that they used asbestos in their hospital.

9 Dec 2018

People with rare cancers can benefit from genomic profiling, shows research

New research has shown that many Australians with rare cancers can benefit from genomic profiling. The findings of the patient-driven trial are being presented today at the Clinical Oncology Society of Australia Annual Scientific Meeting and could result in dramatic changes to the way those with rare cancers are diagnosed and treated.

14 Nov 2018

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor T cell therapy at fighting solid tumors.

23 Oct 2018

New discovery links proteins that control DNA packaging and cancer development

University of Otago scientists have unraveled the 3D structure of two proteins, potentially providing answers as to why some people may be at risk of developing specific cancers.

27 Sep 2018

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research.

10 Sep 2018

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

6 Sep 2018

Mesothelioma News and Research

Further Reading

Secretome of pleural effusions linked to NSCLC and malignant mesothelioma

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Removing asbestos from schools likely to increase cases of mesothelioma

Researchers discover novel cancer-promoting molecular mechanism

New study points out simple problem with existing model of cancer

Mesothelioma patients twice as likely to survive when treated with high dose of radiation

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

New combination therapy found to be well tolerated in patients with aggressive brain tumor

World's largest AI-powered medical research network launched by OWKIN

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Asbestos found in most NHS hospitals finds BBC inquiry

People with rare cancers can benefit from genomic profiling, shows research

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

New discovery links proteins that control DNA packaging and cancer development

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Study finds increase in lifestyle-related cancers over the past decade

International researchers succeed in stopping growth of mesothelioma in model animals

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News